Interactions between rheumatoid arthritis antibodies are associated with the response to anti-tumor necrosis factor therapy

Blocking of the Tumor Necrosis Factor (TNF) activity is a successful therapeutic approach for 50 –60% of rheumatoid arthritis (RA) patients. However, there are yet no biomarkers to stratify patients for anti-TN...

Source: BMC Musculoskeletal Disorders - April 21, 2021 Category: Orthopaedics Authors: Antonio Juli à, María López-Lasanta, Francisco Blanco, Antonio Gómez, Isabel Haro, Antonio Juan Mas, Alba Erra, Ma Luz García Vivar, Jordi Monfort, Simón Sánchez-Fernández, Isidoro González, Mercedes Alperi, Raúl Castellanos-Moreira, Antonio Fer Tags: Research article Source Type: research